The Prevalence of Primary Aldosteronism in Screening Populations: Is Hypokalaemia Important?
Experimental and Clinical Endocrinology & Diabetes · 01.06.2023 · 131 (06) · 375-376
DOI: 10.1055/a-2075-0735 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.06.2023. Verfasst von David M Williams und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Endocrinology, Morriston Hospital, Swansea, SA6 6NL. Hauptthemen laut MEDLINE: Hypokalemia, Hyperaldosteronism, Hypertension. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Diabetes and Endocrinology, Morriston Hospital, Swansea, SA6 6NL.
- Department of Acute Medicine, Morriston Hospital, Swansea, SA6 6NL.
- Department of Laboratory Medicine, Morriston Hospital, Swansea, SA6 6NL.
Zitieren
APA
Williams, D. M., Shaikh, A., Williams, E., Maroof, A., Michael, T., & Boregowda, K. (2023). The Prevalence of Primary Aldosteronism in Screening Populations: Is Hypokalaemia Important?. Experimental and Clinical Endocrinology & Diabetes, 131(06), 375-376. https://doi.org/10.1055/a-2075-0735
Vancouver
Williams DM, Shaikh A, Williams E, Maroof A, Michael T, Boregowda K. The Prevalence of Primary Aldosteronism in Screening Populations: Is Hypokalaemia Important?. Experimental and Clinical Endocrinology & Diabetes. 2023;131(06):375-376. doi:10.1055/a-2075-0735
BibTeX
@article{Williams2023,
author = {Williams, David M and Shaikh, Ayesha and Williams, Ellen and Maroof, Aiman and Michael, Therese and Boregowda, Kusuma},
title = {The Prevalence of Primary Aldosteronism in Screening Populations: Is Hypokalaemia Important?},
journal = {Experimental and Clinical Endocrinology & Diabetes},
year = {2023},
volume = {131},
number = {06},
pages = {375--376},
doi = {10.1055/a-2075-0735}
}
EUVIMED